SITE RESERVED FOR PROFESSIONALS
Level 2 · Controlled trialRandomised controlled trial
Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo-controlled trial
Mikkelsen SU, Al-Mousawi A, Puglisi AB, Vallentin AP, Mortensen AØ, Madaj Z, Hinoue T, Ottesen HN, Jespersen JS, Gillberg L, Tulstrup M, Hansen NR, Hansen JW, Andersen MK, Thomas SL, Isaguirre C, Sheldon R, Adams M, Burgos R, Baylin S, Mortensen BK, Lee O'Connell C, Tang Severinsen M, Laird PW, Lykkesfeldt J, Jones P, Grønbæk K
Cancer · 1 October 2026
AUTHORS’ ABSTRACT
The abstract of this article is not reproduced here: its licence does not allow it. It can be read freely on the journal’s website or on Europe PMC.
Scientific information content; it does not replace the advice of a healthcare professional. The presence of a study in this library does not constitute a claim about our products.
← All studies